Publicaciones en las que colabora con MARÍA DOLORES BOYANO LÓPEZ (22)

2023

  1. A Universal Antigen-Ranking Method to Design Personalized Vaccines Targeting Neoantigens against Melanoma

    Life, Vol. 13, Núm. 1

  2. Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

  3. Melanoma Clinical Decision Support System: An Artificial Intelligence-Based Tool to Diagnose and Predict Disease Outcome in Early-Stage Melanoma Patients

    Cancers, Vol. 15, Núm. 7

  4. Melanoma and Nevi Subtype Histopathological Characterization with Optical Coherence Tomography

    Life, Vol. 13, Núm. 3

2022

  1. Association of TYR SNP rs1042602 with Melanoma Risk and Prognosis

    Life, Vol. 12, Núm. 12

2020

  1. BRAF V600E mutational load as a prognosis biomarker in malignant melanoma

    PLoS ONE, Vol. 15, Núm. 3

  2. Serum markers improve current prediction of metastasis development in early-stage melanoma patients: a machine learning-based study

    Molecular Oncology, Vol. 14, Núm. 8, pp. 1705-1718

2019

  1. Imaging Mass Spectrometry–Based Lipidomic Approach to Classification of Architectural Features in Nevi

    Journal of Investigative Dermatology, Vol. 139, Núm. 9, pp. 2055-2058.e7

2018

  1. Metastasis of cutaneous melanoma: risk factors, detection and forecasting

    Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)

2016

  1. Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I–II early-stage melanoma

    International Journal of Cancer, Vol. 139, Núm. 7, pp. 1598-1607

2015

  1. Comparison of the transcriptional profiles of melanocytes from dark and light skinned individuals under basal conditions and following ultraviolet-B irradiation

    PLoS ONE, Vol. 10, Núm. 8

2014

  1. Involvement of ANXA5 and ILKAP in susceptibility to malignant melanoma

    PLoS ONE, Vol. 9, Núm. 4

  2. The Interplay between natural selection and susceptibility to melanoma on allele 374F of SLC45A2 gene in a south European population

    PLoS ONE, Vol. 9, Núm. 8

2011

  1. A customized pigmentation snp array identifies a novel snp associated with melanoma predisposition in the slc45a2 gene

    PLoS ONE, Vol. 6, Núm. 4

  2. Terfenadine induces apoptosis and autophagy in melanoma cells through ROS-dependent and -independent mechanisms

    Apoptosis, Vol. 16, Núm. 12, pp. 1253-1267

2010

  1. The diversity profile of TP53 is influenced by positive selection on the immediately upstream locus WDR79

    Human Heredity, Vol. 69, Núm. 1, pp. 34-44

2008

  1. Complex signatures of selection for the melanogenic loci TYR, TYRP1 and DCT in humans

    BMC Evolutionary Biology, Vol. 8, Núm. 1

2006

  1. H1 histamine receptor antagonists induce genotoxic and caspase-2-dependent apoptosis in human melanoma cells

    Carcinogenesis, Vol. 27, Núm. 9, pp. 1787-1796

2000

  1. Interleukin-2 enhances the growth of human melanoma cells derived from primary but not from metastatic tumours

    European Cytokine Network, Vol. 11, Núm. 4, pp. 654-661

  2. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma

    British Journal of Cancer, Vol. 83, Núm. 7, pp. 847-852